Reported side effects are generally mild and may include: Redness, swelling, or discomfort at the injection site Mild headache Fatigue (usually short-lived) Minor and transient changes in blood sugar (rare) AOD-9604 does not appear to cause the joint pain, fluid retention, or glucose dysregulation commonly seen with full hGH therapy
BPC-157 is strictly supplied for laboratory research use only and is not approved for medical, cosmetic, or dietary applications.
Choose 2mL (5mg/mL) if: You are starting retatrutide for the first time Your current dose is 5mg per week or lower You want maximum measurement accuracy You prefer straightforward math Choose 1mL (10mg/mL) if: Your dose is 6mg per week or higher You want smaller injection volumes You are comfortable with precise syringe measurements You have experience reconstituting peptides Some researchers start with 2mL during their initial escalation phase and switch to 1mL once they reach maintenance doses above 4mg
Studies across gastrointestinal, musculoskeletal, neurological, vascular, and inflammatory models consistently show BPC-157 acts as a pleiotropic compound
Beyond 8 weeks
Understanding where they fit helps make informed decisions
